Podcasts about Urology

I have hypothyroidism.  Do I need to be concerned about low ferritin levels?What are the benefits of lower-dose fish oil?Is there a connection between melatonin supplementation and depression?Can I take melatonin while on warfarin?What to do about the state of our healthcare system?

Are children's IQs going down?An overview of medical reversalsCan you comment on the melatonin and heart failure study?Result of a prostate artery embolization

Our ‘Family Planning Division' has been busy! a few weeks ago it was Anne from Georgia playing ambulance driver with her post-vasectomy-reversal hubby moaning in the back seat. This time, Kara is pregnant with twins as a result of a botched vasectomy. Urology is a tougher racket than we thought. Boy have we got questions on this episode of the Best of Car Talk.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In part 2 of this 3-part series, Dr Terris discussed the disparities in treatment and outcomes for women with bladder cancer. Although bladder cancer is less common in females than in males, female patients tend to have significantly worse outcomes, Terris explained. Delayed diagnosis is a contributing factor, but the exact reasons for the poorer prognosis are not fully understood, she emphasized. Treatment difficulties begin surgically, according to Terris. From a surgical perspective, she noted that, performing a cystectomy on a woman is more challenging due to factors like pelvic varicosities and differing fat distribution, which complicate stoma creation. In terms of medical treatment, Terris also explained that women exhibit worse tolerability and higher rates of discontinuation of immunotherapy, and that they often experience poor efficacy outcomes regardless of whether they complete the course of treatment. These differences between men and women may be linked to factors such as hormonal influences or antibody introduction during pregnancy. Conversely, classic cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy have been shown to have similar overall survival and disease-free survival in eligible female and male patients. Biologically, Terris also reported that tumors in women may exhibit more effective immune escape mechanisms, possibly connected to differences in the bladder microbiome. The presence of bacteria in bladder tumors has been found to be enriched in patients who did not respond to neoadjuvant chemotherapy, which is relevant as women are more prone to bladder colonization, she added. Overall, Terris emphasized that oncologists must be aggressive in treating women with bladder cancer, despite surgical complexities, and highlighted that early detection is key.

In Episode 5, “Role Models in Academic Urology: The WUO Perspective” of the series “Women in Urology: Dare to Thrive”, Dr. Sarah Psutka and Dr. Sima Porten reflect on the role of mentorship, collaboration and visibility through the lens of the Women in Urologic Oncology (WUO). They discuss how WUO has become a platform for fostering diversity, leadership and professional growth, creating opportunities for women to contribute to academic excellence and clinical innovation.The speakers share how mentorship within WUO has helped strengthen global connections and inspired new generations of female urologists to pursue academic and leadership paths. They highlight the organisation's achievements in promoting inclusivity, scientific exchange and balanced representation in urologic oncology.This episode celebrates not only personal journeys but also the collective progress of women who are redefining academic success through shared purpose and collaboration.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this episode Maria Satchi sits down with Tina Rashid and Tharani Nitkunan to explore surgical leadership, gender bias, motherhood in surgery, and the pursuit of balancing high-pressure careers. For anyone who's ever wondered if they could lead without losing themselves, this episode offers real stories, honest reflections, and the reassurance that leadership can be both powerful and personal. Host: Maria Satchi Maria Satchi is a Consultant Urological Surgeon with subspecialist expertise in Men's Sexual and Reproductive Health. She qualified in 2009 from the University of Southampton in 2009 with a Bachelor or Medicine and Bachelor of Science with Honours degree. She has completed advanced training in male fertility, andrology and genito-scrotal reconstruction during the prestigious competitive fellowship at the Institute of Andrology, University College London Hospital. Early in her career she established a regional andrology and male fertility service, introducing advanced microsurgical techniques. In her current practice, she is the Clinical Lead for the Andrology and Male Factor Infertility Service at a tertiary referral centre.  She sits on professional committees as an elected member of the British Association of Urological Surgeons' national Andrology and Genito-Urethral Surgery Committee and the Andrology Special Interest Group of the British Fertility Society. She currently serves on the advisory board of Fertility Alliance to improve public awareness and access to specialist care and was selected for the 2024 RCS Emerging Leader programme. She is published in the field of urology and andrology and is a member of the editorial board of Trends in Mens' Health and Urology. Guest: Tina Rashid  Tina Rashid is a Consultant Urological Surgeon with extensive experience in gender surgery, and one of only a small number of surgeons in the UK practicing exclusively in this field. She leads the NHS gender surgery service at Nuffield Health Parkside Hospital and co-leads the service at Chelsea and Westminster Hospital NHS Trust, having previously worked as a consultant at Imperial College Healthcare NHS Trust and St George's University NHS Trust. She has been the National Clinical Lead for Gender Dysphoria Surgery at NHS England since 2022, where she is a strategic advisor focusing on national policy, workforce training, and service expansion.  A passionate educator, she developed and leads the London Gender Surgery Fellowship Programme—the first of its kind in the UK—and, as a former Training Programme Director for Urology Higher Surgical Trainees, brings significant experience in training, education, and mentorship to support the next generation of surgeons. A Keith Yates Gold Medal recipient who has performed more than 1,500 lower feminising surgeries, she continues to champion equity, inclusion, and compassion within surgical leadership and practice. Her greatest lessons, however, have come from being a mother to two young children, who remind her daily of the importance of patience, perspective, and purpose—both in and beyond the operating room. Guest: Tharani Nitkunan Tharani Nitkunan has been a consultant urological surgeon since 2013 and specialise in female urology, paediatric urology and HoLEPs. She has been a clinical lead for five years, a BAUS trustee since the beginning of 2025, had various roles in education (foundation year 1 training programme director and member of the urology specialist advisory committee) and audit (BAUS audit steering group). She is a mother to two teenagers and a dog. Resources:sexism-in-medicine-bma-report-august-2021.pdf https://jamanetwork.com/journals/jamasurgery/fullarticle/2808894 https://www.urologynews.uk.com/features/features/post/supporting-return-to-clinical-practice https://jamanetwork.com/journals/jamasurgery/article-abstract/2768006 https://publishing.rcseng.ac.uk/doi/full/10.1308/rcsbull.2022.23?mobileUi=0 Produced by: Andrea Pearson

Urinary tract infections — or UTIs — aren't the most glamorous topic, but they're incredibly important, and we just don't talk about them enough. If you've ever had one, you'll know how miserable they can be: the burning, the stinging, those endless trips to the loo, the pain, and that bone-crushing fatigue. They can really knock you sideways.For many women, UTIs become more common — and more stubborn — during perimenopause and menopause.In this episode, I'm joined by the brilliant Helen Lake, a specialist urology nurse, to help us understand why UTIs happen, why they mustn't be ignored, and what you can do about them — from medical treatments to nutrition and supplements.Helen explains everything you need to know about identifying, understanding, and managing UTIs — and hopefully banishing them for good. We cover the key symptoms, prevention strategies like staying hydrated and double-voiding, why test results aren't always conclusive, and when antibiotics are needed. We also look at the role of beneficial bacteria, cranberry and D-mannose, vaginal moisturisers, topical oestrogen, and how to advocate for yourself with your GP.If you've found this episode helpful, please share it with a friend who might benefit too. And if you love The Happy Menopause podcast, I'd be so grateful if you could leave a five-star rating and a quick review on Apple Podcasts — or wherever you like to listen.And don't forget to subscribe, so you don't miss out on upcoming episodes. These small steps make a huge difference to the algorithm, and help more women find the show.After all, every woman deserves to have a happy menopause.Check out the full Show Notes for this episode on my website www.well-well-well.co.uk/podcast, where you'll find all the relevant links and references for each guest. Learn how to build your own menopause diet to manage your symptoms with my book The Happy Menopause: Smart Nutrition to Help You Flourish. And if you're tired of feeling tired and grappling with brain fog, check out my new book: The Happy Menopause Guide to Energy; Nutrition to Rejuvenate Your Brain & Body. It's available in all the usual places.

Considering a reconstructive urology fellowship or already in the thick of it? This episode is for you. Dr. Rachel Mann (University of Minnesota) sits down with Dr. George Koch (Ohio State University) to discuss her journey in reconstructive urology and the mentors who shaped it. Together, they explore how creativity, adaptability, and mentorship fuel progress in this evolving subspecialty.---SYNPOSISDr. Mann also shares practical advice for residents and fellows who are planning their next steps in training. She reflects on how to identify the right fellowship, make the most of a unique learning year, and transition effectively into independent practice. The episode closes with a discussion of the future of reconstructive urology, including global health opportunities, the potential for dedicated transgender surgery fellowships, and the mindset required to continue evolving as a reconstructive surgeon.---TIMESTAMPS00:00 - Introduction03:01 - Training and Mentorship11:09 - The Evolution and Scope of Reconstructive Urology32:49 - The Future of Reconstructive Urology35:01 - Expanding Internationally38:24 - Rapid Fire Advice for Residents45:59 - Advice for Fellows---RESOURCESThe Trauma and Urologic Reconstructive Network of Surgeons (TURNS)https://www.turnsresearch.org/Optilume ROBUST III trialhttps://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.312RD-180 Suture Devicehttps://pubmed.ncbi.nlm.nih.gov/35070820/

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University.  In part 1 of this 3-part series, Dr Terris discussed the prevalence of bladder cancer in women, as well as reasons for diagnostic disparities that contribute to poor treatment outcomes. She noted that this disease is often diagnosed at later stages in women than in men, often resulting in diagnoses of more advanced disease and translating to poorer outcomes. She added that although female patients represent a minority of those with urothelial carcinoma, retrospective data indicate that women tend to be diagnosed at later stages and consequently experience worse survival rates, regardless of the disease stage. Dr Terris identified several theories explaining why this diagnosis delay occurs. One possible reason is patient-related: women may be less likely than men to consult a physician when they notice blood in their urine because they may be conditioned to dismiss blood if they experience menstrual bleeding. However, physician behavior and bias also contribute to diagnostic disparities, Terris said. Women with suspected hematuria typically receive fewer imaging tests, she continued. Additionally, physicians may be biased, attributing hematuria to uterine bleeding, menstruation, or other benign causes.  Overall, Terris emphasized that early detection is key. If there is any suspicion of a malignancy, patients should be referred directly to a urologist, she stated. Urologists should be willing to work up cases that might ultimately be recurrent urinary tract infections or radiation cystitis to avoid undiagnosed cases of bladder cancer in women, she concluded.

In this episode, let's talk with Dr Baboudjian, from Marseille, about the systematic biopsies.Discover:Is this the end of systematic biopsies?The rise of transperineal biopsiesPractice evolution still unevenHosted by Ausha. See ausha.co/privacy-policy for more information.

Infertility isn't only a women's issue, though too often, it's talked about like it is. In this episode, we're digging into male factor infertility: what it means, how it's diagnosed, and how it impacts couples emotionally, physically, and relationally. We're joined by Paul Kassebaum, a quantum physicist, and his wife Julia Cohen, an economist, who live in Westchester, NY. In 2021, their family-building journey took an unexpected turn with a diagnosis of male factor infertility. They open up about the medical and emotional twists and turns of their path, and why they hope sharing their story will help others feel less alone. To give us a full picture, we also bring in experts: Dr. Ariel Moradzadeh, a reproductive endocrinologist, and Abbe Golding, a genetic counselor at Jscreen. Together, we explore: What male factor infertility actually is, what the causes are, and how it's evaluated Who should be doing the testing and why it matters The role genetics can play in male infertility The emotional and psychosocial impact on men and couples How couples like Paul and Julia navigate the unexpected and find resilience Whether you're directly facing male factor infertility, supporting a partner, or simply learning more about the different paths to parenthood, this conversation is a mix of story, science, and support. Note: This episode is the 3rd of a series of 5 that we are collaborating on with Jscreen in 2025.  Take a look at our previous two episodes here : Episode 157: Introduction to Genetics and Infertility Episode 166: Fragile X Syndrome: A Silent Factor in Infertility About Paul Kassebaum and Julia Cohen: Paul Kassebaum (Kass-eh-bomb) and Julia Cohen live in Westchester, NY where Paul is a quantum physicist and Julia is an economist. In 2021 they were forced to reconsider how to start a family when presented with a diagnosis of male factor infertility. They hope that by sharing both the medical and emotional aspects of their journey they can be a resource for other couples navigating the infertility space. About Dr. Ariel Moradzadeh: Dr. Ariel Moradzadeh attended medical school at The David Geffen school of medicine at UCLA. Following medical school, he completed his General Surgery internship and Urology residency at Cedars-Sinai Medical Center, where he developed his passion for men's health and male infertility. Following residency, he completed an andrology, men's health, male and infertility fellowship at UCLA, and he now works as a full-time reproductive Urologist at Cedars-Sinai. When he is not treating patients, he enjoys running, swimming, weight lifting and yoga. About Abbe Golding: Abbe Golding is a certified genetic counselor and works as a community education and outreach manager for JScreen. She is passionate about providing genetic knowledge that empowers individuals to make informed healthcare decisions. Abbe believes that accurate and relatable genetic information should be accessible to everyone. Abbe lives in Raleigh, North Carolina with her husband and daughter. Connect with JScreen -visit their website here -check out their instagram Connect with us: -Check out our Website -Follow us on Instagram and send us a message -Watch our TikToks -Follow us on Facebook -Watch us on YouTube -Connect with us on LinkedIn

Chuck P returns to Second Line Brewing in New Orleans and talks with owner Mark Logan about Taproom Talks, an educational series that the brewery is hosting in November. The first one is on Tuesday, November 4th, and focuses on men's sexual health led by Dr. Lawrence Jenkins, an Associate Professor of Urology & Director of Men's Health, Tulane University School of Medicine. The discussion will focus on sexual function and male infertility. This event is free and open to everyone.Also, 10% of all sales on November 4th will be donated to the Movember Foundation, supporting men's health initiatives across the globe. You can find out more information on this event by visiting Second Line Brewing's Facebook page.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-abv-podcast--5595170/support.

Chuck P returns to Second Line Brewing in New Orleans and talks with owner Mark Logan about Taproom Talks, an educational series that the brewery is hosting in November. The first one is on Tuesday, November 4th, and focuses on men's sexual health led by Dr. Lawrence Jenkins, an Associate Professor of Urology & Director of Men's Health, Tulane University School of Medicine. The discussion will focus on sexual function and male infertility. This event is free and open to everyone.Also, 10% of all sales on November 4th will be donated to the Movember Foundation, supporting men's health initiatives across the globe. You can find out more information on this event by visiting Second Line Brewing's Facebook page.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-abv-podcast--5595170/support.

In Episode 4, “Women surgeons in Latin America: Leading change” of the series “Women in Urology: Dare to Thrive”, Dr. Catalina Solano Mendoza (CO) and Dr. Mariela Corrales Acosta (FR) discuss the evolving role of women surgeons in Latin America.They share their personal experiences and reflect on the progress achieved through mentorship, collaboration and determination. Their conversation highlights the cultural and systemic challenges women still face across the region and the importance of creating networks that promote equal opportunities and professional growth. Both speakers emphasise that representation and solidarity are key to inspiring the next generation of urologists.This episode celebrates the resilience and leadership of women who are driving lasting change in Latin American urology.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Host: Darryl S. Chutka, M.D. Guest: Daniel M. Frendl, M.D., Ph.D. Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I'll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Send us a textUrologist Dr. Yaw Nyame joins Dr. Michael Koren to discuss bladder and prostate cancers. Dr. Nyame talks about his journey through college - including the choice between rock stardom and medical school - and how he got to the Fred Hutch Cancer Center in Seattle. Dr. Nyame explains symptoms, the history, and treatments for prostate and bladder cancer. He tells us "if you have blood in the urine, you definitely want to get to your primary care doctor." He also expands on gaps in cancer outcomes for Black men. Along the way, we weigh benefits and harms of PSA screening and talk honestly about sexual health after treatment.Show Note: Lynch syndrome is a genetic condition also known as hereditary nonpolyposis colorectal cancer (HNPCC). It represents an increased risk of several cancers, including colorectal, endometrial, gastric, ovarian, and pancreatic cancer. It is caused by an error in the DNA mismatch repair mechanism, which normally corrects for random insertions into the DNA code.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Groin bulges, scrotal swelling, and nonpalpable testes are findings that often surface during routine well-child exams, and they can raise immediate questions for pediatricians and families alike. Is this normal? Will it resolve on its own? Or does it require surgical referral? In this episode, we take a closer look at three common genitourinary conditions in children: inguinal hernias, hydroceles, and undescended testes. We diagnose the details to help clarify the evaluation process, management strategies, and referral guidelines that every pediatrician should know.  This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. Joining us is Eric Bortnick, MD. He is a Urologist and Assistant Professor of Urology at the Yale School of Medicine.   Some highlights from this episode include:  How common these conditions are in the pediatric population  When pediatricians can make a difference in these patients lives, versus when referral is really necessary.  Key takeaways to performing a successful physical exam  Creating a safe space for proper diagnosis  For more information on Children's Colorado, visit: childrenscolorado.org. 

65% of men say they avoid seeking medical attention as long as possibleOnly 3 in 5 men go for their annual physical.And in Chicago, men are 10% less likely to have a primary care provider compared to women. And die 6 years earlier than women on average.On today's Block Club Chicago podcast, sponsored by Rush, doctor Zachary Glaser from Rush University's Department of Urology, on how 'Movember' can make a difference. Host - Jon HansenGuest - Dr. Zachary Glaser, Rush University Medical Center Want to donate to our non-profit newsroom? CLICK HEREWho we areBlock Club Chicago is a 501(c)(3) nonprofit news organization dedicated to delivering reliable, relevant and nonpartisan coverage of Chicago's diverse neighborhoods. We believe all neighborhoods deserve to be covered in a meaningful way.We amplify positive stories, cover development and local school council meetings and serve as watchdogs in neighborhoods often ostracized by traditional news media.Ground-level coverageOur neighborhood-based reporters don't parachute in once to cover a story. They are in the neighborhoods they cover every day building relationships over time with neighbors. We believe this ground-level approach not only builds community but leads to a more accurate portrayal of a neighborhood.Stories that matter to you — every daySince our launch five years ago, we've published more than 25,000 stories from the neighborhoods, covered hundreds of community meetings and send daily and neighborhood newsletters to more than 130,000 Chicagoans. We've built this loyalty by proving to folks we are not only covering their neighborhoods, we are a part of them. Some of us have internalized the national media's narrative of a broken Chicago. We aim to change that by celebrating our neighborhoods and chronicling the resilience of the people who fight every day to make Chicago a better place for all.

We have relied on PSA for decades, but what's next in precision screening for prostate cancer? In this episode of BackTable Urology, Dr. Jason Hafron from the Michigan Institute of Urology joins host Dr. Ruchika Talwar to discuss the evolving role of biomarkers and artificial intelligence in prostate cancer screening.---This podcast is supported by:Cleveland Diagnosticshttps://www.isopsa.com/---SYNPOSISTogether, Dr. Hafron and Dr. Talwar examine the ongoing challenges of PSA testing and the promise of next-generation blood-based biomarkers, including 4Kscore and IsoPSA tests. They explore how these advancements are reshaping detection, diagnosis, and risk stratification. The episode also highlights how these tools may improve active surveillance protocols, reduce unnecessary biopsies, and better personalize prostate cancer management for better outcomes.---TIMESTAMPS0:00 - Introduction2:23 - Limitations of PSA10:21 - Limitations of MRI18:08 - Overview of Biomarkers (IsoPSA, 4K, PHI, SelectMDx, MIPS, ExoDx)26:30 - Artificial Intelligence---RESOURCESProstate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trialhttps://jamanetwork.com/journals/jama/fullarticle/2817323 Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSAhttps://pubmed.ncbi.nlm.nih.gov/36965817/ Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyhttps://pubmed.ncbi.nlm.nih.gov/35840465/

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Morgan Roupret (FR), on the results of the ALBAN trial. A phase 3, randomised, open-label, international study of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) vs BCG alone in BCG naïve high-risk, non-muscle invasive bladder cancer.This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this conversation, Dr. Dean Elterman, Associate Professor of Urology at the University of Toronto and a sub-specialist in functional urology, discusses benign prostatic hyperplasia (BPH), a common condition affecting men as they age. He explains the causes, symptoms, and various treatment options available, including medications, traditional surgeries, and minimally invasive procedures. The discussion also touches on the role of AI in improving treatment outcomes and the importance of lifestyle changes in managing BPH. Dr. Elterman emphasizes the need for awareness and proactive management of urinary symptoms.#prostatehealth

Episode 3 of our monthly GU Cast Journal Club and today we focus on one classic paper in Urology, and one from recent times - the ERSPC randomised trial of screening in prostate cancer, and the NIAGARA trial evaluating peri-operative immunotherapy in muscle-invasive bladder cancer. We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. Watch out for Declan getting all misty-eyed recalling when the ERSPC was published back in 2009 (the rest of the team are too young to remember this)! Links to papers below:1. Screening and Prostate-Cancer Mortality in a Randomized European Study NEJM 20092. Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer NEJM 2024GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.Even better on our YouTube channelAbout GU Cast Journal Club:Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology. The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner. The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Nicholas James (GB) on the results of the final survival analysis from the BladderPath trial, a randomised comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In Episode 3, “Women surgeons in Asia – Pioneering progress” of the series “Women in Urology: Dare to Thrive”, Dr. Kinju Adhikari (NP) and Dr. Steffi Kar Kei Yuen (HK) share their experiences as pioneering female surgeons in Asia. Dr. Adhikari recounts her path from Nepal to becoming a leading onco-urologist and robotic surgeon in India, while Dr. Yuen reflects on her work at the Chinese University of Hong Kong and the evolving role of women in urology across the region. Together, they discuss the challenges of gender bias, the importance of perseverance and the growing number of women entering surgical specialities.They highlight the vital role of mentorship, collaboration and supportive professional networks in fostering women's progress in medicine. Both speakers emphasise that while representation has improved, barriers such as societal expectations and limited opportunities still exist. Their conversation explores how passion for patient care and clinical excellence can co-exist with advocacy for equality.Through their exchange, the episode celebrates the determination of women surgeons shaping the future of urology in Asia and inspires the next generation to follow their lead with confidence and purpose.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

October 24, 2025 In episode 264 of the Urology Coding and Reimbursement Podcast, Scott and Mark Painter sit down with Ken Mitchell, PA-C, a nationally recognized expert in men's health and a champion for advanced practice providers (APPs) in urology. Ken shares insights on the growing urology workforce shortage, the evolving role of APPs, and recent payer challenges—like restrictions on APP-administered Xiaflex in Arkansas. He also introduces his nonprofit, Gynecology, which promotes men's health education and training. This episode is a must-listen for practices navigating workforce limitations, payer pushback, and the future of urologic care.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

More on this awareness campaign by the UOAA at ostomy.org/take-action/ as referenced on OneLegUpAlex !

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Prof. Maria De Santis (DE) about the result of the final analysis of the phase III, open-label, randomised POTOMAC trial: Durvalumab (D) in combination with Bacillus Calmette-Guérin (BCG) for BCG-naïve, high-risk non-muscle-invasive bladder cancer (NMIBC). This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this episode, Prof. Scott Tagawa (US), a medical oncologist at Weill Cornell Medicine in New York, discusses the results of PSMAddition - a phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Dr. Dipen J. Parekh is a globally renowned urologic oncologist, healthcare innovator, and leader in academic medicine. He was appointed Executive Vice President for Health Affairs at the University of Miami and Chief Executive Officer of its health system (UHealth) on June 1, 2025. He remains Founding Director of the Desai Sethi Urology Institute and is an accomplished researcher and professor at the University of Miami Miller School of Medicine who holds the Victor A. Politano Endowed Chair in Urology and is widely celebrated for his groundbreaking contributions to the field of robotic-assisted urologic oncology. Having served as Chief Operating Officer of UHealth from 2020-2025, Chief Clinical Officer from 2017-2020, Chairman of the Department of Urology since 2012, Executive Dean of Clinical Affairs at the University of Miami Miller School of Medicine, and Director of Robotic Surgery for UHealth, Dr. Parekh brings a wealth of academic, clinical, administrative, and institutional experience to the role.Over the course of his career, Dr. Parekh has performed more than 6,000 robotic urologic cancer surgeries, making him one of the most experienced practitioners worldwide. He led the groundbreaking RAZOR trial, published in The Lancet in 2018, which established the efficacy of robotic-assisted radical cystectomy as comparable to open surgery for bladder cancer. He is an NCI funded surgeon scientist with over 200 peer reviewed publications in urologic oncology. His dedication to innovation has also included establishing advanced robotic surgery programs in academic centers across the globe.

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Christof Vulsteke (BE) on the design and results of the phase III KEYNOTE 905/EV303 study: Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In Episode 2, “Academic career – The long and winding road?” of the series “Women in Urology: Dare to Thrive”, Dr. Amelia Pietropaolo (GB) and Dr. Carmen Mir (US) explore the opportunities and obstacles women face in building an academic career in urology. They highlight the persistence of gender gaps in leadership, the structural barriers that limit women's access to networks and senior positions, and the pressures of balancing academia with personal life.Both speakers emphasise the value of mentorship and sponsorship, sharing how role models and supportive colleagues helped them progress, while also reflecting on moments when barriers or cultural biases made the journey more difficult. They discuss positive shifts in recent years, including greater awareness of diversity at conferences and in academic societies, while questioning whether current measures go far enough.Their conversation also touches on the importance of collaboration, networking, and building resilient research communities that encourage young urologists to thrive. Finally, they share personal advice for the next generation: seek mentors, stay curious, and remember why you chose research in the first place.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Board-certified urologist Dr. Jason B. Carter explains his role in the diagnosis of testicular cancer."It's important to understand that when you have a diagnosis like testicular cancer, to some degree, the urologist may be the quarterback in the beginning. With testicular cancer, the urologist is going to be the one you meet, get the initial procedures done, and do the post-op follow-up."I'm very fortunate to have an excellent radiation oncologist that I work with, and very fortunate to have a couple of very, very good medical oncologists that I work with."Definitely anytime you have any kind of cancer, including testicular cancer, it is always a team approach." He shares his insights on treating testicular patients at Unity Urology, his practice in East Tennessee. He has been providing quality urologic care since 2003 and opened Unity Urology in 2006 in Greenville, Tennessee. Other urologic conditions to know about: Dr. Carter talks about other urologic conditions such as low testosterone, other hormone therapies for men and women, infertility, incontinence, and erectile disfunction. He is a medical advisor for Aeroflow Urology.Dr. Carter's medical degree is from East Tennessee University. He completed a residency at the University Hospital and clinics in Columbia, Missouri. He is board-certified in urology by the American Board of Urology and a member of the American Urological Association and the Tennessee Medical Association. Send us a textSupport the showFind us on Twitter, Instagram, Facebook & Linkedin. If you can please support our nonprofit through Patreon.

Developed by the AUA Residents and Fellows Committee, each episode of the Training Transformed podcast series features an interview with a urology faculty member and resident physician surrounding an innovative facet of resident education at their institution. Tune in for our second episode as moderator, Dr. Kayla Graham chats with Dr. Ryan Steinberg and Dr. Brent Yelton about the Point-of-Care Ultrasound (POCUS) curriculum developed at the University of Iowa.

Oct. 16, 2025 ~ Urological issues aren't just a concern for men—up to 60% of women will experience conditions like UTIs, incontinence, pelvic pain, or sexual dysfunction. Lloyd Jackson explores how Dr. Priya Patmanabhan at Corewell Health's Women's Urology Center in Royal Oak is changing the narrative. Dr. Patmanabhan explains how her multidisciplinary approach—combining urology, gynecology, pain psychology, and physical therapy—helps women feel heard and supported. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Urological Association of Asia (UAA) Annual Meeting is always a great cultural event with a focus on the local community. And Taipei certainly put on a great show! Lots of fantastic entertainment and great local cuisine, plus of course a great scientific program, with a focus on AI, single port robotic surgery, novel robot systems, and lots more across the breadth of Urology.Join hosts Renu Eapen and Declan Murphy, who bring you a great flavour of UAA in Taipei, speaking to many local and international guests. Even better on our YouTube channelGU Cast Conference Highlights are supported by our Conference Highlights Partner, Bayer China. 

Dr. Hoffman continues his conversation with Dr. Geo Espinosa, one of America's foremost integrative urologists.

Dr. Geo Espinosa, one of America's foremost integrative urologists, dishes on men's urinary problems, natural support for testosterone, and prostate cancer. Lifestyle factors—diet, exercise, sleep and stress reduction—play an important role in all phases of urological health. Dr. Geo explains how he interacts with conventional urologists on the faculty of NYU Langone Medical Center where he practices. Why are men's urinary problems not just a matter of prostate size? How can natural strategies alleviate urinary difficulties without the need for surgery or drugs? Besides saw palmetto, what nutraceuticals can benefit men with urinary problems? Are there really natural herbal alternatives to testosterone? For men with prostate cancer who are under active surveillance, is there anything more that can be done to minimize their chance of eventually needing surgery or radiation? What nutraceuticals, vitamins and minerals have anti-prostate cancer potential?

Urinary incontinence affects millions of women, yet many continue to suffer in silence due to stigma or the misconception that it's just a normal part of aging. Bladder control issues can impact women of all ages, and they are highly treatable, and there are real solutions that can help. On this episode of the Healthier You Podcast, Dr. Ashlee Williams welcomes Dr. Nwamaka Fadahunsi, a board-certified urologist at Kaiser Permanente, to discuss the causes of urinary incontinence and the many tools available to treat it. Dr. Fadahunsi explains the differences between stress and urge incontinence, debunks common myths, and offers practical guidance on what women can do at home. She also outlines the full range of treatment options, including physical therapy, medications, and outpatient procedures, helping women regain control and confidence without relying on pads or assuming surgery is the only answer.  Learn more about Nwamaka Fadahunsi, MD 

"Give Me the Green Life” isn't just a song lyric — it's a movement toward living fully, consciously, and healthily.In this powerful and revealing episode, we dive deep into the male side of fertility — a topic that's been ignored for far too long.Our expert guest joins us to discuss why sperm counts are dropping globally, what lifestyle factors are driving this crisis, and how men can reclaim their reproductive health naturally. From testosterone therapy pitfalls to the truth about saunas, marijuana, and modern stress, this episode uncovers it all.Dr. Justin Houman is a Board-Certified Urologist and fellowship-trained Men's Sexual and Reproductive Health specialist based in Los Angeles. His practice focuses on male fertility, erectile dysfunction, testosterone optimization, sexual performance, Peyronie's Disease, and minimally invasive procedures such as vasectomy reversals and penile implants.As an Assistant Professor of Urology at Cedars-Sinai Medical Center, Dr. Houman is dedicated to mentoring future physicians and advancing men's health through research, innovation, and education. His work has been featured in leading journals, including JAMA and the Journal of Sexual Medicine, and he has presented internationally on topics ranging from male fertility to the impact of wearable technology on health.A second-generation urologist, Dr. Houman completed his medical training at the University of Rochester and Cedars-Sinai, followed by a fellowship in Male Reproductive Medicine and Surgery at UCLA. Fluent in English, Spanish, and Farsi, he is committed to helping men enhance their quality of life through personalized, evidence-based care.

In Episode 1, “Leadership ladder: Creating your path” of the series “Women in Urology – Dare to Thrive”, Dr. Amelia Pietropaolo (GB) and Prof. Maria Ribal (ES) discuss the challenges and opportunities of pursuing leadership in a traditionally male-dominated specialty. Drawing on their personal journeys, they reflect on the persistence of gender stereotypes, the experience of imposter syndrome, and the importance of building confidence through knowledge, hard work, and supportive networks.Their conversation emphasises that leadership is not about following a rigid master plan but about vision, long-term investment, and trust in one's capabilities. Both speakers highlight the transformative role of mentorship and sponsorship, the value of inclusive groups in attracting more women into urology, and the importance of respecting individuality rather than conforming to stereotypes. Practical advice for young urologists includes taking small steps, embracing networking opportunities, and being unafraid to volunteer or step outside of one's comfort zone.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In today's episode, we had the pleasure of speaking with Joseph Jacob, MD, MCR, about the FDA approval of the gemcitabine intravesical system (formerly TAR-200; Inlexzo)​ for the treatment of patients with BCG-unresponsive non–muscle-invasive bladder cancer. Dr Jacob is an associate professor of urology and the director of Urologic Oncology in the Department of Urology at State University of New York Upstate Medical University in Syracuse. In our exclusive interview, Dr Jacob discussed the significance of this approval, key efficacy findings from the pivotal phase 2b SunRISe-1 trial (NCT04640623), and the TAR-200 administration procedure, which he describes as straightforward for practitioners and convenient for patients.

Enuresis, or bedwetting, is one of the most common concerns encountered in pediatrics. It can present as nighttime bedwetting, daytime urinary accidents, or a combination of both. Oftentimes, families and clinicians are left wondering what's typical and what's considered concerning. In this episode, we focus on the evaluation and management of enuresis in children. Each case is influenced by a range of factors including fluid intake, bowel habits, sleep quality and lifestyle routines. While first-line, non-pharmacologic strategies are the cornerstone of care, effective treatment requires attention to detail and a comprehensive approach. This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. In this episode, we are joined by Julie Cheng, MD, an Assistant Professor of Urology at Seattle Children's Hospital and the University of Washington.  Some highlights from this episode include:  Differentiating between types of enuresis  How key elements in pediatric history and physical examination can help diagnose the problem  Evidence-based first-line interventions and when to escalate care  The role behavioral factors, such as sleep or screen time, play in enuresis  For more information on Children's Colorado, visit: childrenscolorado.org. 

October 3, 2025 In this episode, Scott, Mark, and Ray Painter discuss two timely and important topics. First, they break down the current government shutdown and its effects on Medicare claims processing, including the 10-day hold issued by CMS to allow MACs to adjust their systems—especially around telehealth billing. They offer practical recommendations for urology practices, including billing guidance and the use of ABNs during the shutdown.Then, the discussion shifts to artificial intelligence in healthcare. After attending multiple urology meetings and AI sessions, Scott and Mark share real-world observations on how AI is being used across the urology landscape—from ambient documentation tools to claims scrubbing and patient scheduling. They emphasize the importance of human oversight, expertise, and carefully evaluating AI partners before implementing tools in your practice. Ray adds his perspective on the ongoing need for human knowledge and caution when embracing new technology.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

In this episode of Better Edge, Jennifer Miles-Thomas, MD, moderates a thoughtful conversation with Anthony Schaeffer, MD, discussing complicated urinary tract infections (cUTIs) and their management. Dr. Schaeffer, who contributed to the recent IDSA guidelines on cUTIs, emphasizes the need to understand underlying causes of recurrent infections rather than treating them as isolated events. The conversation explores critical topics such as antibiotic resistance, effective treatment strategies and the importance of early intervention in febrile cases.

Developed by the Society of Academic Urologists in partnership with the American Urological Association, the SAU/AUA Urology Match Insider series provides medical students interested in the field of urology an inside look into the Urology Residency Match process. In this episode, medical student, Irene Choi, sits down with Dr. Justin S. Han and Dr. Jennifer K. Yates to discuss ways medical students can prepare for their match interviews. 

September 26, 2025 In this episode, Scott, Mark, and Ray discuss the looming federal government shutdown and how it could impact urology practices—especially telehealth services. They explain the latest developments in Washington, what Medicare and Medicaid payments will look like during a shutdown, and offer practical guidance for handling telehealth visits, front-office operations, and prior authorizations. Mark shares specific strategies and options for practices, including use of ABNs and billing considerations for Medicare Advantage and traditional Medicare patients. The episode wraps with insights on how the shutdown might delay CMS's final rule and the broader implications for AI, reimbursement, and practice management.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I'm joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections.Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today's standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment.Time-Stamped Highlights00:00 – Why fewer incisions + faster recovery are now real in prostate surgery05:40 – Work–life changes that improved health (sleep, exercise, biking)09:10 – Open vs. robotic: why reproducibility (teachability) matters11:05 – Robotics adoption curve: from early resistance to mainstream19:05 – Outcomes today: continence and erections after modern surgery20:10 – “Yes, I'm a surgeon—and here's my bias.” Radical honesty with patients22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT34:00 – Dexterity & visualization: why robots spare nerves with less trauma35:10 – Real-time margin assessment during surgery to reduce positives40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients)49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential52:30 – How to find Dr. Stifelman & closing advice

The Skin Real app is officially LIVE! Download it now. Download my Free Guide 'In My Perimenopause Era' Download the Ultimate Affordable Skincare Guide When was the last time you thought about your vulvar health? If your answer is “never,” you're not alone. Most women avoid talking or even thinking about this part of their body, but during perimenopause and menopause, changes in vulvar and vaginal health can have a huge impact on your comfort, confidence, and quality of life. In this episode, I sit down with Dr. Diana Londoño, a urologist who is breaking the silence on intimate health. We talk about the changes estrogen loss brings—from dryness, itching, painful sex, and recurrent UTIs to the lesser-known issues like bladder urgency and vulvar atrophy. She also explains how simple solutions like vaginal estrogen cream, hormone therapy, and lifestyle tweaks can protect your vulvar health and prevent years of suffering. ✨ Key Takeaways: Why vulvar health is central to your bladder, vaginal, and sexual health during menopause. How to know if your symptoms are normal aging or a red flag that needs further evaluation. The connection between UTIs, GSM (genitourinary syndrome of menopause), and vulvar atrophy. Why vaginal estrogen is safe, preventative, and worth considering even if you're not sexually active. How stress and mindset affect bladder symptoms and overall well-being. If you've ever felt embarrassed, ignored, or confused about what's happening “down there,” this episode will give you clarity and confidence. Dr. Diana Londoño is a Board-Certified Urologist and one of the 10% of urologists in the US who are women and the 0.5% who are Latinx and women.  She is originally from Mexico City and attended Claremont McKenna College for her undergraduate studies and then went on to attend UCLA for medical school.  She completed a 6-year residency in Urology at Kaiser Permanente in Los Angeles.   She has experienced burnout twice, which has led her to write and speak about it to raise awareness and help others. She has published multiple articles in prominent medical platforms, including Medscape, Doximity, Kevin MD, Men's Health, Giddy.com, and WebMD, among others. She is also a contributing author to the books “Thriving After Burnout” and “Medic S.O.S.”  She has also been a guest on numerous podcasts, discussing various topics, including wellness, stress, spirituality, and energy.   Her burnout journey led her to become a certified life coach and founder of Physician Coach Support.com, a peer support platform she ran for 3 years. In 2022, she received the Los Angeles County Medical Association Physician Leadership Award for her work.    She is an international speaker and guest on multiple podcasts, discussing topics such as wellness, boundaries, ego, humanity in medicine, mindset, and mindfulness. She has also been featured on TV on Univision, Telemundo, Mundo Fox, CNN Latino, KCET, and ABC News as a health consultant discussing urological topics.   She is also a Reiki Master, a Pranic Healer and the mother of two determined and joyful 7- —and 9-year-old girls, Daniela and Paloma.   Follow Dr. Londoño here:   Website -https://dianalondonomd.com/ LinkedIn - https://www.linkedin.com/in/dianalondonomd/ Instagram - https://www.instagram.com/dianalondonomd/ YouTube - https://www.youtube.com/@dianalondonomd   Want more expert skin advice without the overwhelm? Subscribe to The Skin Real Podcast wherever you listen, and visit www.theskinreal.com for dermatologist-backed tips to help you feel confident in your skin—at every age. Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin https://www.linkedin.com/in/drminaskin/ Visit Dr. Mina at Baucom & Mina Derm Surgery Website: atlantadermsurgery.com Email: scheduling@atlantadermsurgery.com Call: (404) 844-0496 Instagram: @baucomminamd Thanks for tuning in. And remember—real skin care is real simple when you know who to trust. Disclaimer: This podcast is for entertainment, educational, and informational purposes only and does not constitute medical advice.